NYSE:BWXT
NYSE:BWXTAerospace & Defense

Is BWX Technologies (BWXT) Quietly Redefining Its Moat Through Radiopharmaceutical Supply Security?

On 14 January 2026, BWX Technologies presented at the CJS Securities 26th Annual “New Ideas for the New Year” Investor Conference, highlighting its position in nuclear and medical technologies. A key focus was BWXT Medical’s progress toward FDA approval of a Technetium-99m generator using commercially produced molybdenum, which could strengthen domestic supply security for high-volume diagnostic imaging procedures. We’ll now examine how BWXT Medical’s Technetium-99m generator progress and...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Is It Time To Reassess Luckin Coffee (OTCPK:LKNC.Y) After Strong Market Share Headlines

If you are wondering whether Luckin Coffee at around US$34.15 is still a worthwhile addition to your watchlist, the key question is how its current price lines up with its underlying value. The stock has had mixed recent returns, with a 1.3% gain over the last 7 days, a 1% decline over the last 30 days, a 3.6% decline year to date, and a 34.5% return over the past year. The 3-year return sits at 49.1%, and the 5-year return is very large. Recent news around Luckin Coffee has focused on its...
NYSE:EOG
NYSE:EOGOil and Gas

A Look At EOG Resources (EOG) Valuation After Recent Share Price Rebound

Framing EOG Resources after recent performance EOG Resources (EOG) has drawn fresh attention after a recent rebound, with the stock up 2.5% over the past day and 8% over the past week. This movement invites a closer look at its fundamentals. See our latest analysis for EOG Resources. While the recent 7 day share price return of 7.99% and 1 month share price return of 4.54% suggest short term momentum is building, the 1 year total shareholder return of 16.41% decline and 3 year total...
TSXV:IFOS
TSXV:IFOSChemicals

Global Market's Top 3 Undervalued Small Caps With Insider Action

As global markets kick off the year with a rally, small-cap stocks are drawing attention by outpacing their large-cap counterparts, particularly as the Russell 2000 Index surged by 5.73%. In this environment of rising indices and shifting economic indicators, identifying undervalued small caps with notable insider activity can offer unique opportunities for investors seeking to capitalize on market dynamics.
TASE:NYAX
TASE:NYAXElectronic

Exploring Beisen Holding And 2 High Growth Tech Stocks In Global Markets

As global markets kick off the year with strong rallies, small-cap and value shares have notably outpaced large-cap growth stocks, with indices like the Russell 2000 and S&P MidCap 400 showing impressive gains. In this dynamic environment, characterized by geopolitical tensions and fluctuating economic indicators, identifying high-growth tech stocks such as Beisen Holding requires a focus on companies that demonstrate resilience and adaptability in rapidly evolving sectors.
SZSE:002121
SZSE:002121Electrical

Global Value Stocks Trading At Estimated Discounts Up To 47.7%

As global markets navigate a complex landscape marked by geopolitical tensions and economic data surprises, investors have seen major indexes reach new heights, with small-cap and value shares leading the charge. In this environment, identifying undervalued stocks can be particularly appealing as they offer potential opportunities to capitalize on market inefficiencies while aligning with broader trends of value outperformance.
SHSE:605196
SHSE:605196Electrical

Global Growth Companies With Strong Insider Ownership In January 2026

As global markets begin the year with a strong rally, despite underlying economic concerns such as a weakening U.S. labor market and geopolitical tensions, investors are increasingly focusing on companies that demonstrate resilience and potential for growth. In this environment, stocks with high insider ownership can be particularly appealing as they often reflect management's confidence in the company's future prospects and alignment with shareholder interests.
SEHK:797
SEHK:797Entertainment

Discover 3 Global Penny Stocks With Market Caps Under US$800M

As global markets continue to navigate a complex landscape, U.S. stocks have shown resilience by rallying at the start of the year, with small-cap and value shares leading the charge. In this context, penny stocks—often overlooked yet still significant—represent an intriguing investment area for those seeking growth opportunities in smaller or newer companies. Despite being considered a niche market, these stocks can offer substantial returns when backed by robust financial health. Let's...
TPEX:6826
TPEX:6826Semiconductor

Undiscovered Gems in Global Markets for January 2026

As 2026 begins, global markets have shown resilience with U.S. stocks rallying to new highs despite geopolitical tensions, and small-cap shares leading the charge with impressive gains in indices like the Russell 2000. Amid these dynamic conditions, identifying promising stocks involves looking for companies that can capitalize on unique opportunities within sectors poised for growth or those that demonstrate strong fundamentals and adaptability in a changing economic landscape.
TWSE:5434
TWSE:5434Semiconductor

3 Global Dividend Stocks Yielding Up To 4.3%

As global markets kick off the year with strong performances, investors are navigating a landscape marked by geopolitical tensions and mixed economic signals. Amidst these dynamics, dividend stocks have garnered attention for their potential to offer steady income streams, especially in times of market volatility. In this environment, selecting dividend stocks that balance yield with stability can be an effective strategy for investors seeking consistent returns.
TSX:LUG
TSX:LUGMetals and Mining

Assessing Lundin Gold (TSX:LUG) Valuation After Hitting 2025 Guidance And Laying Out 2026 Targets

Lundin Gold (TSX:LUG) has drawn fresh attention after reporting 2025 operating results at its Fruta del Norte mine, meeting production guidance while processing record ore with higher recoveries and outlining operational targets for 2026. See our latest analysis for Lundin Gold. The production update comes after a strong run in the shares, with a 30 day share price return of 9.14% and a 1 year total shareholder return of over 2.7x. This suggests momentum has been building as investors...
ASX:NTU
ASX:NTUMetals and Mining

Is Northern Minerals' (ASX:NTU) Concentrated Register Quietly Reshaping Its Long-Dated Project Strategy?

Recent coverage has highlighted how ownership concentration and broad shareholder participation at Northern Minerals is shaping governance and strategic influence in its long‑dated mining projects. This focus on who holds power in the register offers investors a clearer view of how decisions may be made and aligned across stakeholders. Next, we examine how this growing interest in Northern Minerals’ ownership structure could influence the company’s broader investment narrative. Uncover the...
NasdaqGS:EZPW
NasdaqGS:EZPWConsumer Finance

A Look At EZCORP (EZPW) Valuation After Earnings Beat And Rating Shift

Why EZCORP’s latest earnings and rating shift matter for investors EZCORP (EZPW) recently reported quarterly earnings that exceeded analyst expectations, coinciding with a move from a “strong-buy” to “buy” rating at one research outlet while other brokerages kept positive views in place. This combination of strong results and a modest rating change gives you a fresh data point to consider when assessing how the pawn-focused lender’s current share price compares with its recent performance and...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed?

Earlier in January 2026, Alumis Inc. reported positive topline Phase 3 ONWARD1 and ONWARD2 results for its oral TYK2 inhibitor envudeucitinib in moderate-to-severe plaque psoriasis and subsequently completed a US$300.05 million follow-on common stock offering at US$17.00 per share. A key angle for investors is how envudeucitinib’s differentiated clinical profile and “pipeline-in-a-pill” potential, including possible applications in systemic lupus erythematosus, could influence Alumis’s...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

Could Caris Life Sciences (CAI)–Everlywell Cancer Test Tie-Up Redefine Its Precision Medicine Positioning?

In early January 2026, Caris Life Sciences announced a partnership with digital health company Everlywell to launch Caris Detect, a multi-cancer early detection blood test that applies whole genome sequencing and AI to identify molecular signals of cancer in the bloodstream, with commercialization planned through Everlywell’s platform in the first half of 2026. This collaboration highlights how advanced genomic screening and consumer-focused digital health distribution could broaden access...
NYSE:RHI
NYSE:RHIProfessional Services

Is Leadership Recognition and Stabilizing Demand Quietly Reframing the Investment Case for Robert Half (RHI)?

Recently, two senior Robert Half executives, Paul F. Gentzkow and George Denlinger, were named to Staffing Industry Analysts’ 2026 North America Staffing 100 list, recognizing their long-term leadership in talent and consulting services. This industry recognition, alongside commentary about resilient consulting operations and easing macroeconomic pressures, highlights how management strength may support Robert Half’s positioning in a gradually improving staffing landscape. We’ll now examine...
NYSE:ARE
NYSE:AREHealth Care REITs

A Look At Alexandria Real Estate Equities (ARE) Valuation After Lawsuits And Impairment-Linked Earnings Shock

Alexandria Real Estate Equities (ARE) is back in focus after investors filed multiple securities class action lawsuits related to its Long Island City property, following weaker than expected 2025 results and a large impairment charge. See our latest analysis for Alexandria Real Estate Equities. The latest legal actions and impairment news come after a volatile stretch where the share price return has recently improved, with a 30 day share price return of 18.41% and year to date share price...